JUST IN: FDA Committee greenlights emergency authorization of Johnson & Johnson COVID vaccine
DELMARVA — An FDA Vaccine Advisory Panel voted unanimously Friday night to approve emergency use authorization of the Johnson and Johnson coronavirus vaccine.
This means its now up to the FDA to make a final decision, which is expected soon. Unlike the Pfizer and Moderna vaccines, the Johnson and Johnson version only requires one shot. This will make it easier to distribute amongst Americans. The vaccine can also be stored at normal refrigeration temperatures.
Top medical experts say the FDA could green-light the vaccine as soon as this weekend of Feb. 26th, making shots available the week of March 1st.
The CDC’s advisory committee on immunization practices, is set to meet on Sunday to vote on whether the CDC should okay the vaccine’s distribution and may also designate priority groups.